NeuroScientific stem cell studies show kidney transplant promise

NeuroScientific Biopharmaceuticals’ stem cell therapy helped 80% of a small group of renal patients retain donor kidneys and showed safety in transplants, supporting a push into the US$7.2B immunotherapy market